Literature DB >> 17207049

Management of the newborn infant affected by maternal opiates and other drugs of dependency.

Julee Oei1, Kei Lui.   

Abstract

Illicit drug use during pregnancy is common and probably underestimated in the majority of published studies. The infant exposed to opiates or other drugs of dependency during intrauterine development is at risk for post-natal withdrawal as well as to long-term problems that are associated with drug-effects and often, adverse social circumstances. This article examines the early management of the infant and mother for detection and monitoring of drug-exposure, pharmacological intervention for withdrawal and the management of associated, particularly infective and psychosocial, problems. Practical concerns surrounding these issues are discussed and further research on psychosocial intervention to improve long-term outcome are much needed.

Entities:  

Mesh:

Year:  2007        PMID: 17207049     DOI: 10.1111/j.1440-1754.2007.00994.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  10 in total

1.  Neonatal abstinence syndrome: a policy perspective.

Authors:  I J Chasnoff; S Gardner
Journal:  J Perinatol       Date:  2015-08       Impact factor: 2.521

2.  Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Authors:  Ursula A Pritham; Jonathan A Paul; Marie J Hayes
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-02-29

3.  Perinatal outcome of illicit substance use in pregnancy--comparative and contemporary socio-clinical profile in the UK.

Authors:  Nitin Goel; Dana Beasley; Veena Rajkumar; Sujoy Banerjee
Journal:  Eur J Pediatr       Date:  2010-09-09       Impact factor: 3.183

4.  Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations.

Authors:  Elizabeth E Krans; Gerald Cochran; Debra L Bogen
Journal:  Clin Obstet Gynecol       Date:  2015-06       Impact factor: 2.190

Review 5.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

Review 6.  Neonatal abstinence syndrome: treatment and pediatric outcomes.

Authors:  Beth A Logan; Mark S Brown; Marie J Hayes
Journal:  Clin Obstet Gynecol       Date:  2013-03       Impact factor: 2.190

7.  Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea.

Authors:  Anthony Liu; Tracey Björkman; Caroline Stewart; Ralph Nanan
Journal:  Int J Pediatr       Date:  2011-05-23

8.  Research and policy priorities for addressing prenatal exposure to opioids in Alaska.

Authors:  Rosalyn Singleton; Amanda Slaunwhite; Mary Herrick; Matthew Hirschfeld; Laura Brunner; Christine Hallas; Sarah Truit; Sally Hanson; Margaret Young; Evelyn Rider
Journal:  Int J Circumpolar Health       Date:  2019-12       Impact factor: 1.228

9.  Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.

Authors:  Ludmila N Bakhireva; Rajesh C Miranda; Amanda H Mahnke; Melissa H Roberts; Lawrence Leeman; Xingya Ma
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

10.  Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience.

Authors:  Mirjana Vucinovic; Damir Roje; Zoran Vucinovic; Vesna Capkun; Marija Bucat; Ivo Banovic
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.